Skip to content
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Concord Biotech Ltd

CONCORDBIO.NS ✓ COMPLIANTFree checks used up today ☆ Track — members
NSE · Healthcare · Pharmaceuticals ·
India Small Cap Analyst: BUY
Last Close
$16.48
▲ +5.69%
Market Cap $1.72B · Vol 561.32K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
60.03
FWD: 41.05
Market Cap
$1.72B
Small Cap
Div Yield
0.51%
Annual dividend
EPS Growth
+32.55%
YoY
RSI (14)
66.15
Momentum
Beta
N/A
vs Market
52W High
$17.69
19.46% below
52W Low
$10.30
48.38% above
Volume
561.32K
Avg 183.70K
P/B
5.28
Price-to-book
ROE
13.80%
Return on equity
Free Float
27.52%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, Concord Biotech Ltd (CONCORDBIO.NS) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

  • AAOIFI
  • Dow Jones Islamic (DJIM)
  • FTSE Shariah
  • MSCI Islamic
  • S&P Shariah
  • Al Rajhi
  • Alinma
  • Albilad
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CONCORDBIO.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
+4.89%
1M
+0.52%
3M
+20.10%
6M
+44.59%
YTD
+17.38%
1Y
-6.83%
3Y
+41.74%
5Y
N/A
Financials & Valuation
Total Revenue$112.87M
Net Income$27.74M
Revenue Growth (YoY)+26.23%
Gross Margin58.64%
Operating Margin28.10%
Net Profit Margin24.57%
ROE13.80%
ROA · ROIC16.15% · 13.62%
P/E Ratio60.03
Forward P/E (FY1)41.05
PEG Ratio-1.37
P/S10.10
P/B5.28
P/FCF61.29
EPS Growth+32.55%
Outstanding Shares104.62M
Technical Indicators
50-Day SMA$14.90
200-Day SMA$13.24
RSI (14)66.15
BetaN/A
52-Week High$17.69
52-Week Low$10.30
Volume Today561.32K
Avg Daily Volume (30D)183.70K
Relative Volume3.06x
Volatility (10D)35.76
Volatility (30D)35.33
Free Float27.52%
AAOIFI Certified Shariah Advisor and Auditor certificate